Home > Article > Atrial fibrillation management in older heart failure patients: a complex clinical problem
Arrhythmia, Atrial fibrillation, Heart failure
Read Time: < 1 min

Atrial fibrillation management in older heart failure patients: a complex clinical problem

Published Online: August 20th 2018 Heart International. 2016;11(1):e41-e49
Quick Links:
Article Information

Background. Atrial fibrillation (AF) and heart failure (HF), two problems of growing prevalence as a consequence of the ageing population, are associated with high morbidity, mortality, and healthcare costs. AF and HF also share common risk factors and pathophysiologic processes such as hypertension, diabetes mellitus, ischemic heart disease, and valvular heart disease often occur together. Although elderly patients with both HF and AF are affected by worse symptoms and poorer prognosis, there is a paucity of data on appropriate management of these patients. Methods. PubMed was searched for studies on AF and older patients using the terms atrial fibrillation, elderly, heart failure, cognitive impairment, frailty, stroke, and anticoagulants. Results. The clinical picture of HF patients with AF is complex and heterogeneous with a higher prevalence of frailty, cognitive impairment, and disability. Because of the association of mental and physical impairment to non- administration of oral anticoagulants (OACs), screening for these simple variables in clinical practice may allow better strategies for intervention in this high-risk population. Since novel direct OACs (NOACs) have a more favor - able risk-benefit profile, they may be preferable to vitamin K antagonists (VKAs) in many frail elderly patients, especially those at higher risk of falls. Moreover, NOACs are simple to administer and monitor and may be associ - ated with better adherence and safety in patients with cognitive deficits and mobility impairments. Conclusions. Large multicenter longitudinal studies are needed to examine the effects of VKAs and NOACs on long-term cognitive function and frailty; future studies should include geriatric conditions.


Atrial fibrillation, Cognitive impairments, Elderly, Frailty, Heart failure, Oral anticoagulants

Article Information:

Financial support: This article was made possible by an unrestricted
grant from Pfizer S.r.l.

Further Resources

Related Content In Heart failure
  • Journal articles and more to your inbox

    Get the latest clinical insights from touchCARDIO

    Sign me up!
    Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowlinkmenumore_dots padlock person play-colourAsset 1podcastprinter search share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrow